MENA Newswire, WASHINGTON: U.S. regulators have classified a recall affecting more than 80,000 single serve coffee pods made for Keurig brewers after a labeling error raised concerns for consumers who avoid caffeine. The action covers McCafé Premium Roast Decaf Coffee K-Cup pods distributed by Keurig Dr Pepper, according to the U.S. Food and Drug Administration’s recall listing.
The FDA categorized the action as a Class II recall on Jan. 23, 2026. A Class II classification is used when use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or when the likelihood of serious adverse health consequences is remote. The issue involves mislabeling rather than contamination.
The recall involves about 960 cartons of McCafé Premium Roast Decaf K-Cup pods sold in 84 count packages. The affected lots were distributed in California, Indiana, and Nevada. The company initiated the recall on Dec. 6, 2025, and the FDA later published the classification and product identifiers in its recall information.
Consumers checking pantries are advised to look for cartons and pods labeled “decaf” that may contain caffeinated coffee. The affected product can be identified by a best by date of 17 NOV 2026 and a batch number of 5101564894, along with a material number of 5000358463 on the packaging. The listing also includes an online catalog identifier commonly used in e-commerce.
Product details and identification
The recall centers on the difference between what consumers expect from a decaffeinated product and what may be inside the pods. For people who manage caffeine intake for health or dietary reasons, the FDA’s recall notice signals a risk of unwanted caffeine exposure and the potential for short term effects consistent with the agency’s Class II definition.
The FDA’s information indicates the pods were sold in 84 count cartons through retail channels in the three states. The best by date and batch number are key identifiers because similar McCafé K-Cup products may remain available and are not necessarily affected. Only the specific lots listed in the recall information are covered by the action.
Consumers who have the recalled cartons and need to avoid caffeine are advised not to use the pods. The guidance for affected buyers is to discard the product or return it to the place of purchase for a refund or replacement, depending on retailer policies. The recall notice focuses on correct labeling so consumers can make informed choices.
What consumers can do
The FDA’s classification underscores that labeling accuracy is treated as a safety issue when it can lead to unintended exposure, particularly for sensitive groups. The agency’s recall framework is intended to help the public identify specific products, understand the level of risk, and take straightforward steps to remove affected items from use.
Keurig Dr Pepper’s recall listing includes the product name, package size, distribution locations, and the identifying numbers consumers can use to match a carton to the recalled lot. Shoppers who are uncertain can compare the best by date and batch number on their packaging against the FDA listing before deciding whether to return or dispose of the pods.
